Share Structure

It's worse than you think.

And rampant dilution is NEVER a good thing.
Especially with an AS of about 400,000,000
available and waiting at their disposal.

Before you know it, they will increase that AS
by another 100M, setting up for the R-Split.

Believe Me... the "Surprises" will not be good.

Wow... That's A Lot Of Bold-Type

It's another 14,300,000 common shares that will be dumped into the market. And the investor will short them at even a lower pps, and still not lose anything. As the Company continues to give away more and more proprietary assets, while continuously devaluing itself with every collaboration.

" Forward-Looking Statements "
... they will get you every time.

Not So Perfect

The company has the chance to dilute another 14,300,000 shares, and then the investor shorts it on the dilution. A wash deal for the investor, and another bad deal leading to more dilutive pressure on the pps.

And when you start to think about it, there really wasn't any revenues for the 3rd Qtr. Just some carryover from the 2nd Qtr. Any cash would have been absorbed by operational expenses, which is high. Not to mention the debt owed, which is also high. And now adding the strong possibility of some very heavy ATM dilution.

" Forward-Looking Statements "
... they will get you every time.

Convertible Notes

Yes, more notes.

To be converted (diluted) into common shares.
That investor could probably end up shorting
them too... might make more money that way.

This is reality people.

Too Much Friction

So like any organism, this stock has been infected by a virus. This has caused it to over heat in order to kill the virus. And the only way for it to survive is to get the temperature back down to a normal level. The "pump" has created an illness that must now be cured. It is now just entering the ICU, trying to get healthy again. And the only way to get healthy is by letting its temperature get back down to a normal level, like maybe 0.75 degrees, or whatever temp it needs in order to survive. Maybe even 0.60 .

And what investor wants to risk getting infected at this high of a temperature, with so much recovery still required. Once the virus is killed it then needs to convalesce, or consolidate for a while, before determining its true health status. A complete physical and risk evaluation is recommended.

beambe... Wow

Comparing those two charts (GEVO / AMRS), they look almost identical. That is a good study and example of a possible AMRS pullback. Do you think we are headed back to 60 cents? And then gradually meander to 0.40 again?

When you really start to think about it, there really wasn't any revenues here in the 3rd Qtr. Just some carryover from the 2nd Qtr. And any cash would have been absorbed by operational expenses, which is high. Not to mention the debt owed, which is also high. And now added in with the strong possibility of heavy dilution. Need to really think about all that.

Technicals

I'm new at this, so I could be wrong. But aren't all of the technicals signaling an overbought condition? Except for the A/D Line, which has already been suggesting some selling?


. . . Hello ?

Pullback ?

Do you think it's a pullback, or just the beginning of a pullback? I don't think the impact of any ATM dilution has even been fully realized yet. I have 5M shares I was planning to sell. I'm worried. But if the ATM dilution is still in full mode, it will be difficult. I'm concerned about the drop on high volume too.

Dang It

Looks like I'm not going to
be able to sell my 5M shares !

I guess that ATM dilution is always gonna have the priority, and jump in front of me every time. I'm really stuck now. Now they own me and I can't get out. What do I do now ?

I have 5M shares to sell at exactly $1.474.

No it doesn't.

It depends how big your microscope is.

How big is yours.

A/D is not spiking.

Dilution Should Not Be Ignored

It seems that ignoring the dilution is the game. Drowned out with repetitive posts, and 6-8 month old news. Rejecting or not acknowledging the concept of dilution and how it relates. So good job on bringing that reality here into the picture. The more this happens, the more obvious and tired any pump-n-dump becomes, imo. And you are right, that Accum/Dist has not budged. In fact it has fallen and just oscillating on the bottom. How could that be ignored. It is also possible the Company is diluting as many shares as possible before it is acknowledged, or it is revealed that any Reverse Split is on the table. In my estimation, the ATM was activated in July and has been ramped-up ever since. Right now they are probably half way done, skimming as much as possible before it hits the fan.

JMO

May Be A Catch-22

I think some traders and investors got caught today in a T+3 trading frenzy, while more strong money was leaving, imo. It is a pattern. This is definitely on the RADAR for dilution and a reverse split. I think "Warren Buffet" would agree to be patient here for a pullback adjustment. This is where that Bull-Trap occurs. The close double top. There may be some sort of downward adjustment ahead.

JMO

RFB - You Are Right

This post is regarding share structure
and it is not - "Off Topic"

I took off the blinders and did a little DD analysis. Since only June 31, the high volume days (over 2M) have totaled about 240M shares. I conservatively figure they have diluted about 15% of that through their ATM (At The Market dilution plan), initiated back in March 2016. That is about 36M common shares diluted to the OS and Float so far in just the past 4 months. Some pumpers have stated that no dilution would be involved with agreements or collaborations. However, the ATM would be a "separate entity" away from those claims. Keep in mind though, these agreements or collaborations have included Warrants that would also be included in future dilutions. Those Warrants total about 20M shares. So I think it's safe to say there has been about 56M shares added so far to the OS & Float, one way or the other. So going off of the last 10-Q (your DD may be more accurate) the diluted OS may have jumped from about 262,000,000 to 318,000,000. And the diluted float from 87,000,000 to 143,000,000 (might be your 147,000,000). It may even be more. And if you average the selling price of 0.60 cents(?), regarding just the ATM portion of 34M shares, that would equal about $22M of the $50M cap on that March ATM. If that is the case, then there is still a lot more dilution ready and waiting in the wings. I am just averaging the 240M shares, the 15%, and the 0.60 cents here, so you can tweak those number any way you want. But yes, pretty close and big dilution nevertheless.

Will they stop ?

The Key

The key is to read the last CC again.

Would like to see us hold around $0.433,
and maybe close around $0.484 today...?

Would also like to see the progress regarding
future plans to increase the manufacturing
capacity for farnesene demand.

See The Light

Seems like we advance on high volume, and then we retest with lower volume. Setting up for that higher level, imo.

Like we have seen, there are just too many diverse applications and revenue streams lined up for AMRS.

No doubt more and more relationships and agreements are on the way. That's good for the Company, the Lenders, and Us.


No short-haired, yellow-bellied, son of tricky trader is gonna mother hubbard soft soap me into thinking this doesn't have more value.

On The Radar

The price is positive from the Lower-PSAR-Dot through the 5-8-10-13-20-34-50 SMA's. Most of these MA's & BB's have previously been coiled. Many MA's have already crossed over each other, and a few are very close. The price is above all recent mid-FIB resistance points that I can see, and the chart seems to be stair-stepping upward in little EW flag patterns.

Also, it looks like the price has closed above the 50-EMA. As far as attention goes for a potential run, I think closing above the 50-EMA is equal in weight to crossing over the $0.50 cent mark. That 50-EMA also corresponds very close to the old Upper-PSAR-Dot before it went positive. All of these things may bring more attention to the radar. The next hill to be conquered is obviously the recent high of $0.495.

We have seen these after-hours block trades before that don't seem to have an effect either way. To me they're a wash. I don't view them as either positive or negative. It could be some sort of swap, or short covering for all I know. Right now after-hours is at $0.465 with a high of $0.47, although on light volume.

It seems that traders may be taking a longer view by forming a base at a higher level. We have had good news and catalysts recently, and I have noticed a delayed reaction to news events that have lead into a run-up on other stocks this year, so maybe that is what's happening here.

This may hit that $0.70 cent area that you guys are talking about without any further news, as people are starting to get it. The closer we get to $1.00 before any further catalysts, the closer to $2.00 we may get once we have some... just speculating.

GLTA - XX

Working It

The only technical barrier that I can see is a somewhat weak descending trend-line around $0.48. Possibly being worked for accumulation. Once that is absorbed, we may continue up imo. We may bounce somewhere between that and the 50-EMA in the meantime.

JMO

Keep Pushing

About 150K shares traded in that $0.447 area earlier, probably traders not sure if it would break through it. Then we recouped about another 150K below it. Then we had about 600K+ shares pushing through and over $0.47. Good Job. Breaking through the 50-EMA around $0.453 with a retest is great imo. Good volume pushes with lower volume retraces, with just a little resistance around that $0.470 midpoint. Possibly no turning back now. If traders grow some balls, we are set up for some serious attention, imo.

GLTA - XX

A Few Technicals

Noticed so far today that both 8-MA's
have crossed up through the 50-SMA.

A close above the $0.45-46 area soon
may get some attention. And may cause
the 20 to cross up over the 34, and then
on up through the 50-SMA (Silver Cross).

Something I have picked-up on during the past 8 months are these "delayed" and "almost" PPO/ADX-Pinchers. That for some reason have had an initial volume/price head-fake at the "almost" pinch, then followed by a few months delay, that then led into sustained momentum upward after a second volume spike. I don't know if that means anything here... but it may be happening now with AMRS.

EOM

BIOGEN

Haven't heard about BIIB getting into
lubricants. Do you have any data?

I don't recall the Amyris & Biogen relationship being about lubricants. What is big about this relationship and the biopharmaceutical sector is the use of proteins ... and in that field, proteins are used for "everything" .


From The CC & August 3rd PR

<< The Biogen partnership is one of the most exciting projects we have in our portfolio, and it has the ability to make a transformative change to the biopharmaceutical sector.

The project is focused on using Amyris's advanced microbe engineering technology to evaluate and develop multiple host microorganisms as alternatives to mammalian cell lines for the production of therapeutic recombinant proteins.

What this means is that our partner would be able to employ a more efficient production process using our engineered organisms versus using cells from mammals in their R&D and production efforts.

When successful this could be a game-changing development when it comes to the effective and more efficient production of biopharmaceuticals.

Biogen will fully fund this project with the first phase expected to be completed within 12 months. >>


Just so you know . . .
There is huge money in this sector that is currently very interested in revamping obsolete processes, and implementing newer up-to-date technologies for the management of future costs and competition.


EOM

New Lumber

Some stuff on Amyris & Ginkgo Timeline :

June 28 --- The Partnership
Amyris and Ginkgo Bioworks enter into a Strategic Partnership Agreement. A PR and Form 8-K were released the following day.

June 29 --- The PR
The two Companies announced a new partnership, which will enable the Companies to jointly develop products more efficiently and cost effectively, accelerating time to market. The partnership is expected to generate over $300 Million in incremental value for both Companies over the next 5 years.

June 29 --- The SEC Form 8-K
This Form 8-K stated some of the terms. Like how Amyris was going to transfer certain intellectual property over to Ginkgo by June 30 in exchange for a fee of $20 Million Dollars to be paid by Ginkgo to Amyris in two installments, plus a 10% royalty --- Remember, these money transactions always correspond to the transferring of proprietary intellectual property from one company to the other.

Also mentioned in this Form 8-K, was that Amyris would also issue to Ginkgo an option to purchase about 5 Million shares of common stock at an exercise price of 50 cents --- This was the warrant issued a few weeks ago (current Form D) in exchange for and in connection with the transfer of certain information technology... but this time from Ginkgo to Amyris.

So it sounds typical... like the mutual swapping of intellectual information in exchange for some form of money, from both sides of the table, as being part of the consummation process of the agreement.

July --- The $20 Million Dollars
The $15 Million first payment to Amyris was received around this time and will be accounted for as revenue in this current July-Sept quarter. The remaining $5 Million second payment will be made to Amyris by March 31, 2017.

August 6 - Warrant Issued
The warrant that was suggested in the June 29 Form 8-K is issued to Ginkgo from Amyris, as per the agreement.

August 9 --- The SEC Form 10-Q
On page 54 they state that the warrant was officially issued to Ginkgo on August 6, and is in connection with the transfer of certain information technology from Ginkgo to Amyris.

August 19 --- The SEC Form D
Since the warrant/shares were a small amount and are not registered, a Form-D (notice of exempt offering) is to be filed within 15 days. For example, this same form was used when the Bill and Melinda Gates Foundation bought that 5 Million shares or so, not that long ago.

My Take
If you read between the lines it sounds like they are telling you that by issuing the warrant it finalizes the definitive partnership agreement, by now allowing the transfer of proprietary info-technology from Ginkgo to Amyris (Amyris had already transferred to Ginkgo their own info-tech for $20M). This may have been the last step in completely consummating the relationship. Maybe that's just one of the reasons that started the build-up in the stock's activity.

Analogy
This may be a close analogy, but let's say you have all of these big Contractors and Companies that build homes and buildings that require lumber. They all rely on lumber yards for their material. So now a new Lumber Company comes along that provides a new type of lumber that is made from a new disruptive and less expensive material and process. So one-by-one all of those big Building Companies start switching over to this new type of lumber. Or... a new computer-chip manufacturing Company comes up with a better and less expensive chip manufacturing material and process, for supplying chips for all of those end user products. Maybe that's not a good analogy, but Amyris is something like that. A buyout is always a possibility, especially if they keep building their base interest with big-named Companies and Organizations like they have been doing.

Will be interested to see what Amyris has lined up next.


GLTA

Some Information

A Form-D shows investments in small growing companies through partnerships like venture capital and angel investors. This is part of their partnership agreement with Ginkgo Bioworks. This is somewhat old news and part of what they are working on. These filings are released within 15 days. Just like 8-K filings are released within 5 days.


Previously Stated In August 9th 10Q

<< On August 6, 2016, the Company issued to Ginkgo Bioworks, Inc. (or “Ginkgo”) a warrant to purchase 5,000,000 shares of the Company’s common stock at an exercise price of $0.50 per share, exercisable for one year from the date of issuance. Pursuant to the Initial Strategic Partnership Agreement, dated June 28, 2016, between the Company and Ginkgo, such warrant was contemplated to be issued in connection with the execution of a definitive partnership agreement by the Company and Ginkgo setting forth the terms of a long-term commercial partnership and collaboration arrangement between the parties. The warrant was issued prior to the execution of such definitive partnership agreement in connection with the transfer of certain information technology from Ginkgo to the Company. >>

This is part of their strategic growth relationship agreement with Ginkgo. It's not like they went out and filed 100 Million shares for equity offerings and huge dilution. It's a small exempt offering that raises capital. So you see, relationships are not suppose to be free for either party. They are investing in, and working with, each other.

GLTA

The "Teaser" Program

Looks like 170K vol took it from
$0.440 to $0.448, and then about
30K vol took it back to $0.440
... then to normal programming.

Maybe that leaves a back-door
open for a higher close today.

It all depends if the MM's can get back from
lunch early enough and drunk enough to delete
today's program before the Market closes.

Just kidding, I think.

All Right Then

Right on cue.

Computer Program Is Set

I guess $0.443 is just too much to ask from today's Market Maker Pre-set Computer Program. I bet you guys $1,000,000 that this won't go over $0.443 today. That was the opening level of the 20-day upper BB. If it breaks $0.443, it will be a good day.

I may put an order in to buy 1000 shares at $0.444 just to prove that today's Pre-set Computer Program won't allow it. I know the market is rigged & everything, and that these days everyone trades against a Computer Program instead of Real People, while the MM's are out having a 6 hour lunch... but do they really have to make it so obvious?

If there is some kind of Computer-Glitch and this dose break above $0.443 today, it will close above $0.48 imo. But that may screw up the program they have set for tomorrow, when they are scheduled for that all-you-can-eat buffet lunch Harbor Cruise on the Hudson (drinks not included) / $70.00 a head).

Just kidding about the Million Dollars

The Loading Zone

Hang On

Technicals and Fundamentals look great.

JMO

This Will Retrace

That volume was set-up in advance to sell. This is a Bull-Trap while keeping only the tip of the candle barely breaching the 50-SMA into the eod. Think about it. It was a set-up. This will retrace. You need to trade this stock only, and with extreme prejudice.

Someone could have easily written an opposite opinion SA-Blog, and without the use of those clever disclaimers. It's a joke to me when a Company has to resort to using removed-third-parties in order to make up and invent some false catalyst, to justify a generated price action or income for themselves, because they don't have a real one to offer. And at the expense of shareholders running off a cliff.

After burning through assets they will eventually disperse every Authorized Share throughout time to keep up operations, while positioning themselves for a 1-for-20 reverse split. Their revenue is weak and their debt is 75 times the cash and growing. The margins are good but they have a lot of expanding overhead.

This isn't a slam on the Company or product per se... because as a Company you ultimately do what you have to do to survive, while using "Forward-Looking Statements" to your full advantage. Things are NOT what this SA-Blogger claims. He states no definitive position on any opinions. It's nothing more than a warm & fuzzy snow job.

AMRS will retrace. You need to trade this stock only, and with extreme prejudice.

JMO

S A Blog Is a Red Flag

Sellers today. Not going to hold this during irrational buying based on someone's slanted opinion using verbiage laced with clever disclaimers. This will retrace quite a bit. This is obviously orchestrated with Market-Makers and two other 'entities' for dilution. Do not trust that SA-Pumper. It is a set-up. Do you really think this little run today is just a coincidence? Pat yourself on the back if you sold. This new SA-Pumper is actually saying that there WILL be dilution in the very same clever wording he uses when telling you that there won't be. As in many other statements while twisting misused facts. It is so obvious. Wish AMRS had more foresight than to resort to this type of pandering.

You need to read some of these "set-up and well-placed" SA-Blogs with an attorney's eye. I have been waiting for this type of false-event for sellers to sell into, and for the inevitable dilution. And I was right.

JMO

In Case You Are Wondering

PLX is in a horizontal accumulation channel.
It is building up pressure before the breakout.

Approximate Data
Outstanding Shares = 100M
Float = 60M
Institution = 35%
Insiders = 15%
Shorts = 1%
Lots Of Cash

Earnings Getting Better


The ICELL8 is an undeniable asset.

Loses Narrowing
Revenues Rising
Guidance Expanding
No Negative Surprises

Personally I think WaferGen will beat their
own guidance. Their products, especially
the ICELL8, will prove to be necessities.

Imo WGBS is currently completing a pattern.
Maybe S&P500 retests 1950 while WGBS
channels sideways, then breakout to upside.

Earnings After Close


Pattern should continue
if no negative surprises.

Fiscal Year / Corp Update


Everything looks good / on track ,
as pattern continues to develop .

http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-news&nyo=0

use site-map to navigate website

PLX Doing Nicely


Working the ascending channel
to fill the gap from two days ago.

Institutes Using ICELL8


ICELL8 is being accepted as a research tool.

http://ir.wafergen.com/press-releases/detail/1363/wafergen-bio-systems-announces-placement-of-icell8

WaferGen's products are being recognized.

News PRX-102


Excellent Phase I/II Data
SPA is filed with the FDA
Phase III will start soon

http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-newsArticle&ID=2145546

Use the Site-Map to Navigate PLX's Website

Insider Buy


Yossi Maimon CFO
Dec 14, 2015
Direct Purchase At $0.78
10,000 Common Shares